Columbia Laboratories (CBRX)
|
0.6298
+0.0116 (+1.88%)
|
|
|
|
CBRX additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
CBRX Profile
•
Exchange
NASDAQ
•
Held by these Mutual Funds
DFA U.S. Small Cap Value II
Vanguard Extended Market Idx
Bridgeway Ultra-Small Company Market
Vanguard Instl Ttl Stk Mkt Idx InstlPlus
iShares Russell Microcap Index
Fidelity Spartan Extended Mkt Index Inv
Vanguard Balanced Index
DFA US Micro Cap I
DFA US Small Cap I
SA US Small Company
Vanguard Extended Market Idx
Bridgeway Ultra-Small Company Market
Vanguard Instl Ttl Stk Mkt Idx InstlPlus
iShares Russell Microcap Index
Fidelity Spartan Extended Mkt Index Inv
Vanguard Balanced Index
DFA US Micro Cap I
DFA US Small Cap I
SA US Small Company
•
Executives
Mr. Frank C. Condella Jr.
Chief Exec. Officer
Pres and Director
Mr. Lawrence A. Gyenes
Chief Financial Officer
Principal Accouting Officer Sr. VP and Treasurer
Mr. Michael McGrane
Sr. VP
Sec. and Gen. Counsel
Dr. Cristina Csimma D. Pharm. P
53
Lead Scientific Director Director and Member of Compensation Committee
Dr. George William Creasy M.D.
Exec. Officer
Chief Exec. Officer
Pres and Director
Mr. Lawrence A. Gyenes
Chief Financial Officer
Principal Accouting Officer Sr. VP and Treasurer
Mr. Michael McGrane
Sr. VP
Sec. and Gen. Counsel
Dr. Cristina Csimma D. Pharm. P
53
Lead Scientific Director Director and Member of Compensation Committee
Dr. George William Creasy M.D.
Exec. Officer
•
Employee Count
24
Special Offers
Competitors
CBRX earnings
Date
Actual
Expected
Prev Yr Qtr
11/8/2012
0.01
0.01
-0.01
8/8/2012
0.02
0.00
0.13
5/4/2012
-0.01
0.01
0.08
